These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 34141721)

  • 1. Nano-Medicines a Hope for Chagas Disease!
    Choudhury SD
    Front Mol Biosci; 2021; 8():655435. PubMed ID: 34141721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in nanocarriers as drug delivery systems in Chagas disease.
    Quijia Quezada C; Azevedo CS; Charneau S; Santana JM; Chorilli M; Carneiro MB; Bastos IMD
    Int J Nanomedicine; 2019; 14():6407-6424. PubMed ID: 31496694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From Benznidazole to New Drugs: Nanotechnology Contribution in Chagas Disease.
    Gomes DC; Medeiros TS; Alves Pereira EL; da Silva JFO; de Freitas Oliveira JW; Fernandes-Pedrosa MF; de Sousa da Silva M; da Silva-Júnior AA
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Navigating drug repurposing for Chagas disease: advances, challenges, and opportunities.
    Porta EOJ; Kalesh K; Steel PG
    Front Pharmacol; 2023; 14():1233253. PubMed ID: 37576826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoparticulate drug delivery systems for the treatment of neglected tropical protozoan diseases.
    Volpedo G; Costa L; Ryan N; Halsey G; Satoskar A; Oghumu S
    J Venom Anim Toxins Incl Trop Dis; 2019; 25():e144118. PubMed ID: 31130996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An overview on the ecology of Triatominae (Hemiptera:Reduviidae).
    Galvão C; Justi SA
    Acta Trop; 2015 Nov; 151():116-25. PubMed ID: 26086951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chagas disease vaccine design: the search for an efficient Trypanosoma cruzi immune-mediated control.
    Bivona AE; Alberti AS; Cerny N; Trinitario SN; Malchiodi EL
    Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165658. PubMed ID: 31904415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene-deleted live-attenuated Trypanosoma cruzi parasites as vaccines to protect against Chagas disease.
    Sánchez-Valdéz FJ; Pérez Brandán C; Ferreira A; Basombrío MÁ
    Expert Rev Vaccines; 2015 May; 14(5):681-97. PubMed ID: 25496192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technological innovation strategies for the specific treatment of Chagas disease based on Benznidazole.
    Ferraz LRM; Alves AÉG; Nascimento DDSDS; Amariz IAE; Ferreira AS; Costa SPM; Rolim LA; Lima ÁAN; Rolim Neto PJ
    Acta Trop; 2018 Sep; 185():127-132. PubMed ID: 29452113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flavonoids and Chagas' Disease: The Story So Far!
    Nabavi SF; Sureda A; Daglia M; Izadi M; Rastrelli L; Nabavi SM
    Curr Top Med Chem; 2017; 17(4):460-466. PubMed ID: 27558676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chagas disease (American trypanosomiasis) in Mexico: an update.
    Carabarin-Lima A; González-Vázquez MC; Rodríguez-Morales O; Baylón-Pacheco L; Rosales-Encina JL; Reyes-López PA; Arce-Fonseca M
    Acta Trop; 2013 Aug; 127(2):126-35. PubMed ID: 23643518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive glycoprofiling of the epimastigote and trypomastigote stages of Trypanosoma cruzi.
    Alves MJ; Kawahara R; Viner R; Colli W; Mattos EC; Thaysen-Andersen M; Larsen MR; Palmisano G
    J Proteomics; 2017 Jan; 151():182-192. PubMed ID: 27318177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanotechnological approaches against Chagas disease.
    Romero EL; Morilla MJ
    Adv Drug Deliv Rev; 2010 Mar; 62(4-5):576-88. PubMed ID: 19941920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A therapeutic nanoparticle vaccine against Trypanosoma cruzi in a BALB/c mouse model of Chagas disease.
    Barry MA; Wang Q; Jones KM; Heffernan MJ; Buhaya MH; Beaumier CM; Keegan BP; Zhan B; Dumonteil E; Bottazzi ME; Hotez PJ
    Hum Vaccin Immunother; 2016 Apr; 12(4):976-87. PubMed ID: 26890466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chagas disease vector blood meal sources identified by protein mass spectrometry.
    Keller JI; Ballif BA; St Clair RM; Vincent JJ; Monroy MC; Stevens L
    PLoS One; 2017; 12(12):e0189647. PubMed ID: 29232402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ecological niche modeling as a tool for understanding distributions and interactions of vectors, hosts, and etiologic agents of Chagas disease.
    Costa J; Peterson AT
    Adv Exp Med Biol; 2012; 710():59-70. PubMed ID: 22127886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of new potent hits against intracellular Trypanosoma cruzi by QSAR-based virtual screening.
    Melo-Filho CC; Braga RC; Muratov EN; Franco CH; Moraes CB; Freitas-Junior LH; Andrade CH
    Eur J Med Chem; 2019 Feb; 163():649-659. PubMed ID: 30562700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current drug therapy and pharmaceutical challenges for Chagas disease.
    Bermudez J; Davies C; Simonazzi A; Real JP; Palma S
    Acta Trop; 2016 Apr; 156():1-16. PubMed ID: 26747009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances and Progress in Chagas Disease Drug Discovery.
    Ferreira LG; de Oliveira MT; Andricopulo AD
    Curr Top Med Chem; 2016; 16(20):2290-302. PubMed ID: 27072717
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.